Hollinsworth John S. 4
4 · Acadia Healthcare Company, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Hollinsworth John S.
EVP of Operations
Transactions
- Sale
Common Stock
2023-11-14$73.51/sh−15,000$1,102,650→ 132,130 total - Sale
Common Stock
2023-11-14$74.00/sh−15,000$1,110,000→ 162,130 total - Sale
Common Stock
2023-11-14$73.66/sh−15,000$1,104,900→ 147,130 total - Sale
Common Stock
2023-11-14$74.00/sh−20,000$1,480,000→ 112,130 total - Sale
Common Stock
2023-11-14$74.50/sh−27,500$2,048,750→ 84,630 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5506 to $73.81, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.50 to $73.68, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.50 to $74.51, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.